Drug Information

Drug General Information
Drug ID
D0Q0XV
Former ID
DNC009440
Drug Name
(1R,2S)-N-Oleoylcyclopropanolamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530070]
Formula
C19H37NO2
Canonical SMILES
CCCCCCCCCCCCCCCC(=O)NC1CC1O
InChI
1S/C19H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(22)20-17-16-18(17)21/h17-18,21H,2-16H2,1H3,(H,20,22)/t17-,18+/m0/s1
InChIKey
LIBNBUULGCFJNR-ZWKOTPCHSA-N
PubChem Compound ID
44591632
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [530070]
Cannabinoid receptor 2 Target Info Inhibitor [530070]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signalinghsa04080:Neuroactive ligand-receptor interaction
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like
References
Ref 530070J Med Chem. 2009 May 14;52(9):3001-9.Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.
Ref 530070J Med Chem. 2009 May 14;52(9):3001-9.Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.